Literature DB >> 8552388

Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers.

G J Clark1, M S Kinch, T M Gilmer, K Burridge, C J Der.   

Abstract

Although experimental studies suggest that aberrant Ras function can promote the malignant progression of human breast epithelial cells, the occurrence of mutated ras genes in breast tumors is infrequent. One possible explanation for this apparent paradox is that aberrant function of the Ras-related protein TC21/R-Ras2, which causes malignant transformation of NIH 3T3 cells via upregulation of the Ras signal transduction pathway, may contribute to breast tumor development in the absence of Ras mutations. To address this possibility, we utilized two complementary approaches. First, we determined that aberrant TC21 function caused transformation of the MCF-10A human breast epithelial cell line. TC21-transformed MCF-10A cells exhibited altered cellular morphology associated with a disruption of cell-cell adherens junctions, formed colonies in soft agar, and showed enhanced motility in vitro. These alterations were similar to, but more dramatic than, those observed with oncogenic Ras-transformed MCF-10A cells. Furthermore, overexpression of normal TC21, but not Ras, also caused transformation of these cells. Second, we observed that TC21 protein expression was greatly elevated in 7 of 9 breast tumor lines when compared to untransformed MCF-10A cells. Taken together, these results support the possibility that overexpression of TC21 may contribute to aberrant growth properties of breast carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8552388

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.

Authors:  M Rosário; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  Essential function for the GTPase TC21 in homeostatic antigen receptor signaling.

Authors:  Pilar Delgado; Beatriz Cubelos; Enrique Calleja; Nuria Martínez-Martín; Angel Ciprés; Isabel Mérida; Carmen Bellas; Xosé R Bustelo; Balbino Alarcón
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

4.  Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C.

Authors:  D D Shock; K He; J D Wencel-Drake; L V Parise
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  TC21 causes transformation by Raf-independent signaling pathways.

Authors:  S M Graham; A B Vojtek; S Y Huff; A D Cox; G J Clark; J A Cooper; C J Der
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.

Authors:  C Frémin; J-P Guégan; C Plutoni; J Mahaffey; M R Philips; G Emery; S Meloche
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

7.  Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.

Authors:  Fuling Zhou; Ming Li; Yongchang Wei; Kevin Lin; Yue Lu; Jianjun Shen; Gary L Johanning; Feng Wang-Johanning
Journal:  Oncotarget       Date:  2016-12-20

8.  Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.

Authors:  Fernando Calvo; Piero Crespo
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

9.  Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.

Authors:  Yuan Huang; Fatima Rangwala; Patricia C Fulkerson; Bo Ling; Erin Reed; Adrienne D Cox; John Kamholz; Nancy Ratner
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

10.  siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.

Authors:  Raghibul Hasan; Shyam Singh Chauhan; Rinu Sharma; Ranju Ralhan
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.